citric acid, anhydrous has been researched along with ferrous citrate in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (12.09) | 18.7374 |
1990's | 22 (24.18) | 18.2507 |
2000's | 15 (16.48) | 29.6817 |
2010's | 29 (31.87) | 24.3611 |
2020's | 14 (15.38) | 2.80 |
Authors | Studies |
---|---|
Apte, SV; Kathoke, S; Rao, BS | 1 |
Fujioka, A; Imagawa, M; Naruse, S; Tsuji, S; Yamaguchi, H | 1 |
Gelfand, EW; Kovar, J; Schleicher, RB; Seligman, PA | 1 |
Kubota, K; Morita, T; Nakazato, K; Sakurai, T; Shirakura, T | 1 |
Kitazono, M; Mitamura, T; Yakushiji, M; Yoshimura, O | 1 |
Beyer, GJ; Franke, WG; Fromm, WD; Henke, E; Maka, G; Schomäcker, K | 1 |
Tsuyuki, H | 1 |
Kojima, S; Kubodera, A; Sasaki, T | 1 |
Chaudhuri, TK | 1 |
Almeida, AM; Castilho, RF; Hermes-Lima, M; Meinicke, AR; Vercesi, AE | 1 |
Fujimori, H; Hasegawa, K; Kasai, M; Komori, M; Kuroda, M; Kuroda, S; Maejima, K; Nagamatsu, K; Ninomiya, R; Samejima, M | 1 |
Chiueh, CC; de Bartolomeis, A; Mohanakumar, KP; Murphy, DL; Peng, SY; Sternberger, LM; Wu, RM; Yeh, KJ | 1 |
Castilho, RF; Kowaltowski, AJ; Meinicke, AR; Vercesi, AE | 1 |
Ohnishi, ST; Ohnishi, T; Sato, S; Tominaga, T | 1 |
Stadtman, ER; Szweda, LI | 1 |
Chiueh, CC; Rauhala, P; Sziráki, I | 1 |
Banba, H; Hiruma, M; Ishibashi, A; Kawada, A; Kimura, M; Marshall, J; Noguchi, H | 1 |
Günther, I; Leenders, KL; Psylla, M; Radü, EW; Roelcke, U; von Ammon, K; Vontobel, P | 1 |
Kubrina, LN; Mikoian, VD; Vanin, AF | 1 |
Briat, JF; Fourcroy, P; Inzé, D; Lopez, F; Vansuyt, G | 1 |
Chiueh, CC; Lin, AM; Rauhala, P | 1 |
Chai, CY; Lin, AM; Yang, CH | 1 |
Andrade, PB; Castilho, RF; Grijalba, MT; Meinicke, AR; Schreier, S; Vercesi, AE | 1 |
Chiueh, CC; Hanbauer, I; Mohanakumar, KP | 1 |
Nonaka, D; Okamura, T; Takaki, K; Taketa, H; Tanaka, M; Umeno, M | 1 |
Chyi, BY; Ho, LT; Hwang, LS; Lin, AM; Wu, LY | 1 |
Castilho, RF; Hermes-Lima, M; Meinicke, AR; Vercesi, AE | 1 |
Chiueh, CC; Rauhala, P; Spooner, CM; Van Bergen, P | 1 |
Kawachi, A; Miyashita, M; Motoya, T; Yamada, K | 1 |
Gautier-Luneau, I; Pierre, JL | 1 |
Ohashi, Y; Yoshinaga, K; Yoshioka, H | 1 |
Andoh, T; Chiueh, CC; Rauhala, P; Yeh, K | 1 |
Chiueh, CC; Chowdhury, R; Mohanakumar, KP; Muralikrishnan, D; Sharma, SM; Thomas, B | 1 |
Golner, S; Hjelmhaug, J; Lobner, D | 1 |
Dainty, JR; Eagles, J; Fairweather-Tait, SJ; Roe, MA; Teucher, B | 1 |
HOLMES, JM | 1 |
TRONCOSO Y TRONCOSO, J | 1 |
FUCHS, K; PERETZ, H; PEYSER, MR | 1 |
NASIO, J | 1 |
Baumane, L; Dambrova, M; Kalvinsh, I; Kirjanova, O; Liepinsh, E; Muceniece, R; Wikberg, JE; Zvejniece, L | 1 |
Juneja, LR; Nakata, K; Nanbu, H; Rao, TP; Sakaguchi, N | 1 |
Kamimura, N; Murayama, N; Sunagane, N; Terawaki, Y; Uruno, T; Yoshinobu, E | 1 |
Curti, C; Delgado, R; Inada, NM; Pardo Andreu, G; Velho, J; Vercesi, AE | 1 |
Almeida, AM; Bertoncini, CR; Borecký, J; Souza-Pinto, NC; Vercesi, AE | 1 |
Chang, SG; Xu, X | 1 |
Pham, AN; Waite, TD | 1 |
Akizawa, T; Mizobuchi, M; Sanada, D | 1 |
Chen, TY; Chiueh, CC; Hsu, C; Lee, TY; Lee, WS; Tsai, KL | 1 |
Iyama, S; Kato, J; Kawano, Y; Kikuchi, S; Kobune, M; Miyanishi, K; Murase, K; Nagashima, H; Sato, T; Sato, Y; Takada, K; Takimoto, R | 1 |
Cai, LL; Jiang, Y; Li, W; Liu, N; Lu, BH; Zhang, SH | 1 |
Aubry, M; Bouvet, R; Chalès, G; Doyard, M; Fatih, N; Guggenbuhl, P; Island, ML; Leroyer, P; Loréal, O; Monnier, A; Mosser, J | 1 |
Cai, LL; Jiang, JL; Li, W; Liu, N | 1 |
Chen, CW; Chen, TY; Chiueh, CC; Hsu, C; Lee, WS; Lin, CL; Tsai, KL; Yokoyama, KK | 1 |
Chen, LC; Chiueh, CC; Hsu, C; Lee, WS | 1 |
Chen, LC; Lee, WS | 1 |
Abe, F; Fujino, M; Ishii, T; Ishizuka, M; Ito, H; Li, XK; Nagahara, Y; Nakajima, M; Nishio, Y; Takahashi, K; Taketani, S; Tanaka, T; Zhao, M | 1 |
Abe, F; Chen, J; Chen, Y; Fujino, M; Guo, H; Hei, M; Huang, H; Huang, S; Ito, H; Li, J; Li, XK; Ma, X; Nakajima, M; Takahashi, K; Tanaka, T; Wang, J; Zhao, L; Zhao, M; Zheng, S; Zhu, P; Zhuang, J | 1 |
Ikegawa, S; Kamijo, Y; Kataoka, Y; Masuki, S; Morita, A; Nakajima, M; Nose, H; Ogawa, Y; Sumiyoshi, E; Takahashi, K; Tanaka, T | 1 |
Tsai, FP; Wu, TW | 1 |
Chen, TY; Chiang, PC; Hsiao, HW; Hsu, C; Lin, CL; Wang, LF; Yokoyama, KK | 1 |
Doi, S; Kenichiro, S; Masaki, T; Mizuiri, S; Nishizawa, Y; Yamashita, K | 1 |
Chen, J; Fujino, M; Ito, H; Li, XK; Nakajima, M; Nishio, Y; Takahashi, K; Tanaka, T; Zhao, L; Zhao, M; Zhu, P; Zhuang, J | 1 |
Al-Saber, F; Aldosari, W; Alselaiti, M; Darwish, A; Harb, G; Kaladari, A; Khalfan, H; Khan, G; Koda, A; Kudo, S; Nakajima, M; Rehani, R; Tanaka, T | 1 |
Fukuhara, H; Hara, T; Inoue, K; Ishizuka, M; Kamiya, A; Kitajima, Y; Koda, A; Kuroda, Y; Nakagawa, H; Nakajima, M; Ota, U; Shuin, T; Tanaka, T; Tsuda, M; Tsuru, E | 1 |
Fukumitsu, T; Ono, T; Sanai, T | 1 |
Higuchi, T; Imai, R; Koyamada, R; Morimoto, M; Okada, S | 1 |
Kuwabara, M; Tanaka, M | 1 |
Aichi, M; Fukao, W; Hasuike, Y; Iwasaki, T; Kantou, M; Kuragano, T; Masachika, S; Nagasawa, Y; Nakanishi, T; Nanami, M; Takahishi, SI; Toyoda, K; Yahiro, M; Yamakawa, T | 1 |
Kamijo, YI; Masuki, S; Morikawa, A; Nakajima, M; Nose, H; Ogawa, Y; Suzuki, H; Takahashi, K | 1 |
Hara, T; Ito, H; Li, XK; Nishio, Y; Sugihara, H; Tanaka, T | 1 |
Daimon, S | 1 |
Han, J; Wang, C; Wang, Z; Xiao, N; Zeng, B; Zhang, P; Zhao, Z; Zheng, M | 1 |
Fujino, M; Ito, H; Li, XK; Liu, C; Nakajima, M; Takahashi, K; Tanaka, T; Zhu, P; Zhu, S; Zhuang, J | 1 |
Fushimi, T; Ichimoto, K; Ishii, T; Kishita, Y; Matsunaga, A; Murayama, K; Nakajima, M; Nozawa, N; Ogawa-Tominaga, M; Ohtake, A; Okazaki, Y; Shimura, M; Tajika, M; Takahashi, K; Tanaka, T; Tsuruoka, T | 1 |
Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Koshi-Ito, E; Takahashi, K; Tsuboi, N; Yuzawa, Y | 1 |
Fujino, M; Isaka, Y; Ito, H; Li, XK; Liu, C; Nakajima, M; Takahashi, K; Tanaka, T; Zhu, P; Zhu, S | 1 |
Kato, K; Kato, T; Sato, K; Taniai, M | 1 |
Hosogaya, N; Kawakami, A; Koga, T; Sato, S; Shimizu, T; Sumiyoshi, R; Tashiro, S; Yamamoto, H | 1 |
Guo, WZ; Hu, X; Ito, H; Li, XK; Liu, C; Ma, K; Nakajima, M; Que, W; Ren, K; Takahashi, K; Tanaka, T; Wang, Z; Yi, SQ | 1 |
Fujine, K; Inaoka, DK; Kita, K; Kurosaki, Y; Morita, K; Ngwe Tun, MM; Sakura, T; Sakurai, Y; Yasuda, J | 1 |
Arita, K; Hanaki, K; Komatsu, N; Mitsui, H; Nemoto, T | 1 |
Abiru, N; Haraguchi, A; Horie, I; Ito, A; Kawakami, A; Nakamura, Y; Shigeno, R | 1 |
Hu, X; Ito, H; Li, XK; Liu, C; Nakajima, M; Takahashi, K; Tanaka, T; Wang, Z; Zhu, P | 1 |
Guo, WZ; Hirano, H; Hu, X; Ishii, T; Ishizuka, M; Ito, H; Li, XK; Nakajima, M; Nozawa, N; Que, W; Takahashi, K; Tanaka, T; Wang, Z; Zhu, P | 1 |
Alvarez-Almiñaque, D; Armentero-López, A; Bécquer-Viart, MÁ; D'Vries, RF; Fernández-Acosta, R; Marín-Prida, J; Matos-Peralta, Y; Pardo-Andreu, GL | 1 |
Aizawa, S; Ando, K; Asada, A; Iijima, KM; Ishii, T; Ishizuka, M; Noguchi, M; Nozawa, N; Saito, T; Shinno, K; Tajima, M | 1 |
Chatziantonio, C; Negoro, H; Razzaque, MS | 1 |
Elgendy, O; Kitahara, G; Osawa, T; Taniguchi, S | 1 |
Iwanaga, K; Iwashima, A; Kawamura, K; Kojima, T; Matsushima, H; Mitsuishi, Y; Nakajima, M; Nakamura, S; Natsume, I; Nishi, K; Ohsaki, Y; Sakai, H; Sasaki, S; Sasaki, T; Sato, K; Shigenaga, T; Takahashi, K; Taniguchi, H; Yamauchi, M | 1 |
Auwerx, J; Benegiamo, G; Hosoda, S; Kitamura, N; Morel, JD; Nagano, U; Nakamura, A; Ogawa, Y; Taworntawat, T; Tsubota, K; Watanabe, M; Yokoyama, Y; Zhang, S | 1 |
4 review(s) available for citric acid, anhydrous and ferrous citrate
Article | Year |
---|---|
Supplementation of total parenteral nutrition solutions with ferrous citrate.
Topics: Adult; Amino Acids; Animals; Citric Acid; Female; Ferrous Compounds; Food Additives; Humans; Iron; Iron Deficiencies; Male; Parenteral Nutrition; Parenteral Nutrition, Total; Rats | 1985 |
Iron and citric acid: a fuzzy chemistry of ubiquitous biological relevance.
Topics: Citrates; Citric Acid; Ferric Compounds; Ferrous Compounds; Iron; Models, Molecular; Ornithine; Oxidation-Reduction; Siderophores | 2000 |
Nitric oxide: an antioxidant and neuroprotector.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Citric Acid; Disease Models, Animal; Dopamine Agents; Ferrous Compounds; Free Radicals; Humans; MPTP Poisoning; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Substantia Nigra | 2002 |
[Novel phosphate binders under development].
Topics: Bile Acids and Salts; Chronic Disease; Citric Acid; Clinical Trials as Topic; Drug Design; Ferrous Compounds; Humans; Hyperphosphatemia; Kidney Diseases; Polyamines; Risk Factors; Sevelamer | 2009 |
9 trial(s) available for citric acid, anhydrous and ferrous citrate
Article | Year |
---|---|
Impact of 5-aminolevulinic acid with iron supplementation on exercise efficiency and home-based walking training achievement in older women.
Topics: Accelerometry; Aged; Aminolevulinic Acid; Carbon Dioxide; Citric Acid; Cross-Over Studies; Diet; Dietary Supplements; Double-Blind Method; Exercise; Female; Ferrous Compounds; Humans; Lactic Acid; Middle Aged; Oxygen Consumption; Physical Conditioning, Human; Walking | 2016 |
The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain.
Topics: Abdominal Pain; Aminolevulinic Acid; Bahrain; Blood Glucose; Citric Acid; Cough; Diabetes Mellitus, Type 2; Diarrhea; Female; Ferrous Compounds; Glycated Hemoglobin; Humans; Male; Middle Aged; Phosphates; Pilot Projects; Single-Blind Method; Sodium | 2016 |
Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis-Effect on Fibroblast Growth Factor-23 Metabolism.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anemia, Iron-Deficiency; Citric Acid; Dietary Supplements; Female; Ferric Oxide, Saccharated; Ferrous Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Effects of 5-aminolevulinic acid supplementation on home-based walking training achievement in middle-aged depressive women: randomized, double-blind, crossover pilot study.
Topics: Adult; Aged; Aminolevulinic Acid; Citric Acid; Combined Modality Therapy; Depressive Disorder, Major; Dietary Supplements; Double-Blind Method; Exercise Therapy; Female; Ferrous Compounds; Humans; Levulinic Acids; Middle Aged; Muscle Strength; Oxygen Consumption; Walking | 2018 |
Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron.
Topics: Administration, Oral; Adult; Aminolevulinic Acid; Citric Acid; Enzyme Induction; Ferrous Compounds; Heme Oxygenase-1; Humans; Leukocytes, Mononuclear; Male; Photosensitizing Agents; Young Adult | 2018 |
Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant)
Topics: Administration, Oral; Adult; Aminolevulinic Acid; Citric Acid; Drug Therapy, Combination; Female; Ferrous Compounds; Glucocorticoids; Heme; Heme Oxygenase-1; Humans; Japan; Male; Photosensitizing Agents; Pilot Projects; Safety; Still's Disease, Adult-Onset; Trace Elements; Treatment Outcome | 2020 |
Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
Topics: Adult; Anemia, Iron-Deficiency; Citric Acid; Double-Blind Method; Ferric Compounds; Ferrous Compounds; Humans; Japan; Middle Aged; Treatment Outcome | 2021 |
A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus.
Topics: Adenosine Triphosphate; Adult; Aminolevulinic Acid; Blood Glucose; Citric Acid; Deafness; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Ferrous Compounds; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Japan; Levulinic Acids; Male; Mitochondria; Mitochondrial Diseases; Pilot Projects; Treatment Outcome | 2021 |
A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer.
Topics: Adult; Aged; Aminolevulinic Acid; Cisplatin; Citric Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged | 2022 |
78 other study(ies) available for citric acid, anhydrous and ferrous citrate
Article | Year |
---|---|
Mono ferrous acid citrate (FeC6O7H2O) as an iron fortificant.
Topics: Adult; Citrates; Citric Acid; Female; Ferrous Compounds; Food, Fortified; Humans; Intestinal Absorption; Iron; Male; Sex Factors | 1978 |
Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer's disease.
Topics: Alzheimer Disease; Citric Acid; Coenzymes; Drug Therapy, Combination; Female; Ferrous Compounds; Humans; Mental Status Schedule; Middle Aged; Pyridoxine; Ubiquinone | 1992 |
Transferrin-independent iron uptake supports B lymphocyte growth.
Topics: B-Lymphocytes; Burkitt Lymphoma; Calcium; Cell Division; Citric Acid; Ferritins; Ferrous Compounds; Humans; Iron; Receptors, Transferrin; Transferrin; Tumor Cells, Cultured | 1991 |
[Effect of green tea on iron absorption in elderly patients with iron deficiency anemia].
Topics: Aged; Aged, 80 and over; Anemia, Hypochromic; Citric Acid; Female; Ferrous Compounds; Humans; Intestinal Absorption; Iron; Middle Aged; Tea | 1990 |
[The influence of green tea upon the improvement of iron deficiency anemia with pregnancy treated by sodium ferrous citrate].
Topics: Adult; Anemia, Hypochromic; Citric Acid; Drug Evaluation; Female; Ferrous Compounds; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications, Hematologic; Tea; Transferrin | 1989 |
The influence of isotopic and nonisotopic carriers on the biodistribution and biokinetics of M3+-citrate complexes.
Topics: Animals; Citrates; Citric Acid; Ferrous Compounds; Gallium; Gallium Radioisotopes; Iron; Iron Radioisotopes; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Radioisotopes; Thulium; Tissue Distribution | 1986 |
[The mechanism of iron uptake by primary cultured rat hepatocytes].
Topics: Animals; Cells, Cultured; Citric Acid; Female; Ferrous Compounds; Iron; Liver; Rats; Rats, Inbred Strains; Transferrin | 1987 |
Relation between 67Ga uptake and iron metabolism in rat tissues.
Topics: Animals; Carbon Tetrachloride Poisoning; Citric Acid; Ferrous Compounds; Gallium Radioisotopes; Glucosephosphate Dehydrogenase; Glycosaminoglycans; Heparitin Sulfate; Iron; Iron Radioisotopes; Liver; Rats; Uronic Acids; Zinc | 1984 |
Marrow fibrosis studied by ferrokinetics.
Topics: Adult; Anemia; Bone Marrow; Citric Acid; Erythropoiesis; Ferrous Compounds; Humans; Iron; Kinetics; Liver; Male; Metabolic Clearance Rate; Radionuclide Imaging; Spleen | 1981 |
Oxidative damage of mitochondria induced by Fe(II)citrate is potentiated by Ca2+ and includes lipid peroxidation and alterations in membrane proteins.
Topics: Animals; Calcium; Citric Acid; Drug Synergism; Egtazic Acid; Ferrous Compounds; Intracellular Membranes; Iron; Kinetics; Lipid Peroxidation; Membrane Potentials; Membrane Proteins; Mitochondria, Liver; Mitochondrial Swelling; Onium Compounds; Organophosphorus Compounds; Oxygen Consumption; Rats; Rats, Wistar; Ruthenium Red; Time Factors | 1994 |
Effect of iron as a new type of phosphate binder in hemodialysis patients.
Topics: Administration, Oral; Adult; Aged; Citric Acid; Female; Ferritins; Ferrous Compounds; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis | 1995 |
Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Citric Acid; Corpus Striatum; Dopamine; Ferrous Compounds; Free Radicals; Hydroxyl Radical; Kinetics; Lipid Peroxidation; Male; Neurons; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1994 |
Oxidative damage of mitochondria induced by Fe(II)citrate or t-butyl hydroperoxide in the presence of Ca2+: effect of coenzyme Q redox state.
Topics: Animals; Antimycin A; Butylated Hydroxytoluene; Calcium; Citric Acid; Ferrous Compounds; Free Radicals; Mitochondria, Liver; Mitochondrial Swelling; Oxidation-Reduction; Oxidative Stress; Peroxides; Rats; Rats, Wistar; Succinates; Succinic Acid; tert-Butylhydroperoxide; Thiobarbituric Acid Reactive Substances; Ubiquinone | 1995 |
Electron paramagnetic resonance study on nitric oxide production during brain focal ischemia and reperfusion in the rat.
Topics: Animals; Brain; Brain Ischemia; Citric Acid; Ditiocarb; Drug Stability; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Iron; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion | 1994 |
Oxidative modification of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides by an iron(II)-citrate complex.
Topics: Binding Sites; Citrates; Citric Acid; Enzyme Stability; Ferrous Compounds; Glucosephosphate Dehydrogenase; Hydrogen Peroxide; Iron; Leuconostoc; Oxidation-Reduction; Oxygen | 1993 |
Novel protective effect of manganese against ferrous citrate-induced lipid peroxidation and nigrostriatal neurodegeneration in vivo.
Topics: Analysis of Variance; Animals; Citric Acid; Corpus Striatum; Ferrous Compounds; Lipid Peroxidation; Male; Manganese; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1995 |
Photosensitivity due to sodium ferrous citrate.
Topics: Administration, Oral; Anemia; Citric Acid; Ferrous Compounds; Humans; Male; Middle Aged; Patch Tests; Photosensitivity Disorders | 1996 |
Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Citric Acid; Female; Ferrous Compounds; Glioblastoma; Humans; Iron Radioisotopes; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Recurrence; Time Factors; Tomography, Emission-Computed | 1996 |
[Effect of prooxidants on nitric oxide formation in murine liver, treated with bacterial lipopolysaccharide].
Topics: Animals; Citric Acid; Electron Spin Resonance Spectroscopy; Escherichia coli; Ferrous Compounds; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred CBA; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species | 1996 |
Iron triggers a rapid induction of ascorbate peroxidase gene expression in Brassica napus.
Topics: Abscisic Acid; Ascorbate Peroxidases; Brassica; Citric Acid; Cotyledon; Enzyme Induction; Ferrous Compounds; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Plant; Iron; Oxidative Stress; Peroxidases; RNA, Messenger | 1997 |
Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress.
Topics: Animals; Autoradiography; Citric Acid; Cocaine; Dopamine; Ferrous Compounds; Glutathione; Infusions, Parenteral; Iodine Radioisotopes; Lipid Peroxidation; Male; Neurons; Neuroprotective Agents; Nitrates; Nitroso Compounds; Oxidants; Oxidative Stress; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Substantia Nigra | 1998 |
Striatal dopamine dynamics are altered following an intranigral infusion of iron in adult rats.
Topics: Animals; Biosensing Techniques; Citric Acid; Corpus Striatum; Dopamine; Electrochemistry; Ferrous Compounds; Infusions, Parenteral; Iron; Lipid Peroxidation; Male; Oxidative Stress; Rats | 1998 |
Inhibition of membrane lipid peroxidation by a radical scavenging mechanism: a novel function for hydroxyl-containing ionophores.
Topics: Amidines; Animals; Citric Acid; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radical Scavengers; Ionophores; Lasalocid; Lipid Metabolism; Lipid Peroxidation; Liposomes; Mitochondria, Liver; Mitochondrial Swelling; Nigericin; Oxidants; Oxygen Consumption; Rats; Rats, Wistar; Spin Labels; Thiobarbituric Acid Reactive Substances | 1998 |
Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity.
Topics: Animals; Citric Acid; Corpus Striatum; Dopamine; Drug Interactions; Ferrous Compounds; Hydroxyl Radical; In Vitro Techniques; Lipid Peroxides; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1998 |
Gelatinous bone marrow transformation complicated by self-induced malnutrition.
Topics: Anorexia Nervosa; Bone Marrow; Citric Acid; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Nutrition Disorders; Treatment Outcome | 1998 |
The antioxidative property of green tea against iron-induced oxidative stress in rat brain.
Topics: Administration, Oral; Animals; Antioxidants; Brain Chemistry; Chromatography, High Pressure Liquid; Citric Acid; Corpus Striatum; Dose-Response Relationship, Drug; Ferrous Compounds; Lipid Peroxidation; Male; Nerve Degeneration; Neurons; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tea; Vitamin E | 1998 |
Role of Fe(III) in Fe(II)citrate-mediated peroxidation of mitochondrial membrane lipids.
Topics: Animals; Citric Acid; Ferric Compounds; Ferrous Compounds; Intracellular Membranes; Lipid Peroxidation; Membrane Lipids; Mitochondria; Oxygen Consumption; Rats; Rats, Wistar | 1999 |
Hemoglobin and iron-evoked oxidative stress in the brain: protection by bile pigments, manganese and S-nitrosoglutathione.
Topics: Animals; Antioxidants; Bile Pigments; Bilirubin; Biliverdine; Brain; Citric Acid; Deferoxamine; Ferrous Compounds; Glutathione; Hemoglobins; Iron; Lipid Peroxidation; Male; Manganese; Muscle, Skeletal; Nitroso Compounds; Oxidants; Oxidative Stress; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Tissue Extracts | 1999 |
Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice.
Topics: Absorption; Administration, Oral; Animals; Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Citric Acid; Diphosphates; Drug Interactions; Ferrous Compounds; Iron; Iron Compounds; Male; Mice | 2000 |
Kinetic analysis of the effect of (-)-epigallocatechin gallate on the DNA scission induced by Fe(II).
Topics: Antimutagenic Agents; Catechin; Citric Acid; DNA, Bacterial; Escherichia coli; Ferrous Compounds; Kinetics; Nucleic Acid Conformation; Plasmids | 2002 |
Contradictory effects of sodium nitroprusside and S-nitroso-N-acetylpenicillamine on oxidative stress in brain dopamine neurons in vivo.
Topics: Animals; Brain; Citric Acid; Dopamine; Ferrous Compounds; Iron; Male; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine | 2002 |
Neurotrophic factor effects on oxidative stress-induced neuronal death.
Topics: Animals; Buthionine Sulfoximine; Cell Death; Cells, Cultured; Cerebral Cortex; Chromans; Citric Acid; Ethacrynic Acid; Ferrous Compounds; Fetus; Fibroblast Growth Factor 2; Free Radical Scavengers; Insulin-Like Growth Factor I; Mice; Nerve Growth Factors; Neuroglia; Neurons; Oxidative Stress | 2003 |
Quantification of unlabelled non-haem iron absorption in human subjects: a pilot study.
Topics: Administration, Oral; Adult; Citric Acid; Computer Simulation; Female; Ferrous Compounds; Humans; Injections, Intravenous; Intestinal Absorption; Iron; Iron Isotopes; Middle Aged; Models, Biological; Pilot Projects; Sensitivity and Specificity | 2003 |
Ferrous calcium citrate in pregnancy anaemia.
Topics: Anemia; Calcium; Calcium Citrate; Citric Acid; Female; Ferrous Compounds; Iron; Pregnancy; Pregnancy Complications | 1957 |
[The problem of iron deficiency anemia during pregnancy. Immediate responses to calcium ferrous citrate therapy].
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Calcium Citrate; Citric Acid; Ferrous Compounds; Iron; Iron, Dietary; Pregnancy; Pregnancy Complications | 1959 |
[Ferrous calcium citrate in the treatment of anemia in pregnancy].
Topics: Anemia; Calcium; Calcium Citrate; Citric Acid; Ferrous Compounds; Iron; Pregnancy | 1962 |
[TREATMENT OF IRON-DEFICIENCY DIGESTIVE ANEMIA WITH FERROUS CALCIUM CITRATE].
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Calcium; Calcium Citrate; Citrates; Citric Acid; Drug Therapy; Ferrous Compounds; Iron | 1964 |
EPR investigation of in vivo inhibitory effect of guanidine compounds on nitric oxide production in rat tissues.
Topics: Animals; Cerebral Cortex; Citric Acid; Ditiocarb; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Guanabenz; Guanidines; Heart; Injections, Intraperitoneal; Injections, Subcutaneous; Kidney; Lipopolysaccharides; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Testis | 2003 |
Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate.
Topics: Analysis of Variance; Animals; Area Under Curve; Biological Availability; Citric Acid; Diphosphates; Ferrous Compounds; Hemoglobins; Iron; Iron, Dietary; Male; Particle Size; Rats; Rats, Sprague-Dawley | 2004 |
[Simple method for precognition of drug interaction between oral iron and phenolic hydroxyl group-containing drugs].
Topics: Acetaminophen; Animals; Biological Availability; Biopharmaceutics; Citric Acid; Colorimetry; Droxidopa; Drug Interactions; Ferrous Compounds; Iron Compounds; Levodopa; Male; Mice; Mice, Inbred Strains; Suspensions | 2005 |
Mangifera indica L. extract (Vimang) inhibits Fe2+-citrate-induced lipoperoxidation in isolated rat liver mitochondria.
Topics: Animals; Antioxidants; Ascorbic Acid; Citric Acid; Ferrous Compounds; In Vitro Techniques; Lipid Peroxidation; Mangifera; Mitochondria, Liver; Mitochondrial Swelling; Oxidation-Reduction; Oxygen Consumption; Plant Extracts; Rats | 2005 |
Mitochondrial DNA damage associated with lipid peroxidation of the mitochondrial membrane induced by Fe2+-citrate.
Topics: Animals; Citric Acid; DNA Damage; DNA, Mitochondrial; Ferrous Compounds; Lipid Peroxidation; Male; Mitochondria, Liver; Mitochondrial Membranes; Mitochondrial Swelling; Rats; Rats, Wistar | 2006 |
Removing nitric oxide from flue gas using iron(II) citrate chelate absorption with microbial regeneration.
Topics: Absorption; Air Pollutants; Anilides; Azo Compounds; Bacteria; Biodegradation, Environmental; Citric Acid; Ferrous Compounds; Glucose; Iron Chelating Agents; Nitric Oxide; Oxygen; Sewage | 2007 |
Oxygenation of Fe(II) in the presence of citrate in aqueous solutions at pH 6.0-8.0 and 25 degrees C: interpretation from an Fe(II)/citrate speciation perspective.
Topics: Citric Acid; Ferrous Compounds; Hydrogen-Ion Concentration; Iron; Kinetics; Oxidation-Reduction; Solutions; Temperature; Water | 2008 |
Sex-specific role of thioredoxin in neuroprotection against iron-induced brain injury conferred by estradiol.
Topics: Animals; Brain Injuries; Citric Acid; Estradiol; Female; Ferrous Compounds; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sex Characteristics; Thioredoxins | 2010 |
Establishment of a simple test for iron absorption from the gastrointestinal tract.
Topics: Adult; Anemia, Iron-Deficiency; Blood Chemical Analysis; Chronic Disease; Citric Acid; Female; Ferrous Compounds; Gastrointestinal Tract; Humans; Intestinal Absorption; Iron; Male; Middle Aged; Young Adult | 2011 |
Enhanced biological removal of NOχ from flue gas in a biofilter by Fe(II)Cit/Fe(II)EDTA absorption.
Topics: Adsorption; Citric Acid; Edetic Acid; Ferrous Compounds; Filtration; Gases; Microscopy, Electron, Scanning; Nitrogen Oxides | 2011 |
Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.
Topics: Cation Transport Proteins; Cells, Cultured; Citric Acid; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron Overload; Membrane Proteins; Osteoblasts; Oxidative Stress; Phenotype; Quaternary Ammonium Compounds | 2012 |
Characterization and optimization of Fe(II)Cit-No reduction by Pseudomonas sp.
Topics: Cell Proliferation; Citric Acid; Environmental Pollutants; Ferrous Compounds; Hydrogen-Ion Concentration; Nitrogen Oxides; Pseudomonas; Temperature | 2011 |
Inhibition of autophagy as a therapeutic strategy of iron-induced brain injury after hemorrhage.
Topics: Animals; Autophagy; Autophagy-Related Protein 7; Brain Injuries; Castration; Caudate Nucleus; Cerebral Hemorrhage; Citric Acid; Cytoprotection; Estradiol; Estrogen Receptor alpha; Female; Ferrous Compounds; Humans; Iron; Male; Mice; Mice, Knockout; Microtubule-Associated Proteins; Neostriatum; Neurotoxins; PC12 Cells; Protective Agents; Rats; Receptors, Dopamine D2; Sex Characteristics; Signal Transduction; Ubiquitin-Activating Enzymes | 2012 |
Ferrous citrate up-regulates the NOS2 through nuclear translocation of NFκB induced by free radicals generation in mouse cerebral endothelial cells.
Topics: Acetylcysteine; Animals; Binding Sites; Cell Nucleus; Cells, Cultured; Cerebral Cortex; Citric Acid; Endothelial Cells; Endothelium, Vascular; Ferrous Compounds; Free Radical Scavengers; Free Radicals; Male; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Protein Binding; Protein Transport; RNA, Messenger; Transcription, Genetic; Up-Regulation | 2012 |
Estradiol reduces ferrous citrate complex-induced NOS2 up-regulation in cerebral endothelial cells by interfering the nuclear factor kappa B transactivation through an estrogen receptor β-mediated pathway.
Topics: Analysis of Variance; Animals; Blotting, Western; Brain; Chromatin Immunoprecipitation; Citric Acid; DNA Primers; Endothelial Cells; Estradiol; Estrogen Receptor beta; Ferrous Compounds; Gene Expression Regulation; Luciferases; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transcriptional Activation | 2013 |
5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1.
Topics: Aminolevulinic Acid; Animals; Basic-Leucine Zipper Transcription Factors; Cell Line; Citric Acid; Enzyme Induction; Extracellular Signal-Regulated MAP Kinases; Ferrous Compounds; Heme Oxygenase-1; Membrane Proteins; Mice; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; RNA, Small Interfering | 2014 |
5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.
Topics: Aminolevulinic Acid; Animals; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Citric Acid; Ferrous Compounds; Heme Oxygenase-1; Hydrogen Peroxide; Membrane Proteins; Mice; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NF-E2-Related Factor 2; Oxidative Stress; RNA Interference; RNA, Small Interfering; Signal Transduction; Ventricular Myosins | 2015 |
Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Citric Acid; Dietary Supplements; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Male; Middle Aged; Retrospective Studies; Tablets; Taiwan; Treatment Outcome | 2016 |
Knockout of ho-1 protects the striatum from ferrous iron-induced injury in a male-specific manner in mice.
Topics: Animals; Apoptosis; Cerebral Hemorrhage; Citric Acid; Corpus Striatum; Disease Models, Animal; Estradiol; Female; Ferrous Compounds; Heme Oxygenase-1; Male; Membrane Proteins; Mice; Mice, Knockout; Severity of Illness Index; Sex Characteristics; Up-Regulation | 2016 |
Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; C-Reactive Protein; Citric Acid; Dietary Supplements; Female; Ferrous Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2017 |
5-Aminolevulinic acid with sodium ferrous citrate induces autophagy and protects cardiomyocytes from hypoxia-induced cellular injury through MAPK-Nrf-2-HO-1 signaling cascade.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Autophagy; Cell Hypoxia; Chromones; Citric Acid; Enzyme Inhibitors; Ferrous Compounds; Heme Oxygenase-1; Ischemia; Kidney; Macrophages; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Morpholines; Myocytes, Cardiac; Oxidative Stress; Protective Agents; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2016 |
5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.
Topics: 3T3 Cells; Adiposity; Aminolevulinic Acid; Animals; Citric Acid; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ferrous Compounds; Glucose; Glucose Tolerance Test; Male; Mice; Mice, Inbred C57BL; Mitochondria; Obesity | 2017 |
Beneficial Effects of Oral Iron in Japanese Patients on Hemodialysis.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Citric Acid; Erythropoietin; Female; Ferritins; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Iron; Japan; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Transferrin | 2017 |
Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor.
Topics: Anemia, Iron-Deficiency; Citric Acid; Ferrous Compounds; Humans; Iron; Iron Deficiencies; Japan; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2018 |
A Web Effect: Plummer-Vinson Syndrome.
Topics: Adult; Chest Pain; Citric Acid; Esophagus; Female; Ferrous Compounds; Fluoroscopy; Humans; Plummer-Vinson Syndrome; Trace Elements | 2018 |
Efficacy for Anemia and Changes in Serum Ferritin Levels by Long-Term Oral Iron Administration in Hemodialysis Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Citric Acid; Female; Ferritins; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Time Factors | 2019 |
Detection and identification of the oxidizing species generated from the physiologically important Fenton-like reaction of iron(II)-citrate with hydrogen peroxide.
Topics: Citric Acid; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Hydrogen Peroxide; Hydroxyl Radical; Kinetics; Models, Chemical; Oxidation-Reduction; Spectrophotometry | 2019 |
5-ALA/SFC Attenuated Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats.
Topics: Alanine Transaminase; Aminolevulinic Acid; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aspartate Aminotransferases; Binge Drinking; Cell Adhesion Molecules, Neuronal; Citric Acid; Endotoxins; Enterobacteriaceae Infections; Ethanol; Ferrous Compounds; gag Gene Products, Human Immunodeficiency Virus; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hepatitis; HIV Infections; HIV-1; Inflammation Mediators; Intestines; Lipopolysaccharides; Liver; Permeability; Rats; Rats, Transgenic; Receptors, Cell Surface; Sirtuin 1; Stem Cells; Triglycerides; Zonula Occludens-1 Protein | 2019 |
Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Biosynthetic Pathways; Case-Control Studies; Citric Acid; DNA Copy Number Variations; DNA, Mitochondrial; Female; Ferrous Compounds; Fibroblasts; Heme; Heme Oxygenase-1; Humans; In Vitro Techniques; Infant; Infant, Newborn; Male; Mitochondrial Diseases; Oxidative Phosphorylation; Oxygen Consumption; RNA, Messenger; Sodium Citrate; Up-Regulation | 2019 |
Oral ferrous citrate or ferrous sulfate use during predialysis may reduce serum phosphate level at dialysis initiation
.
Topics: Aged; Aged, 80 and over; Citric Acid; Female; Ferrous Compounds; Humans; Male; Middle Aged; Phosphates; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
5-ALA/SFC enhances HO-1 expression through the MAPK/Nrf2 antioxidant pathway and attenuates murine tubular epithelial cell apoptosis.
Topics: Aminolevulinic Acid; Animals; Antioxidants; Apoptosis; Cells, Cultured; Citric Acid; Epithelial Cells; Ferrous Compounds; Heme Oxygenase-1; Kidney Tubules; Levulinic Acids; Mice; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2 | 2019 |
Relationship between the Induced Iron Overload Model and Hepatic Erythropoiesis in
Topics: Animals; Citric Acid; Erythropoiesis; Ferrous Compounds; Iron; Iron Overload; Liver; Male; Models, Animal; Xenopus laevis | 2020 |
5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Topics: Alanine Transaminase; Aminolevulinic Acid; Animals; Aspartate Aminotransferases; Citric Acid; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Ferrous Compounds; Gene Expression Regulation; Graft vs Host Disease; Levulinic Acids; Liver; Male; Mice; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sodium Citrate; T-Lymphocytes; Treatment Outcome; Up-Regulation | 2021 |
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
Topics: Aminolevulinic Acid; Animals; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; Citric Acid; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ferrous Compounds; Humans; Levulinic Acids; Vero Cells | 2021 |
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Topics: Aminolevulinic Acid; Animals; B-Lymphocytes; Blood Urea Nitrogen; Body Weight; CD8-Positive T-Lymphocytes; Citric Acid; Creatine; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrous Compounds; Fibrosis; Graft vs Host Disease; Heme Oxygenase-1; Levulinic Acids; Lupus Nephritis; Lymphocyte Activation; Membrane Proteins; Mice; Spleen; T-Lymphocytes, Regulatory | 2021 |
5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Animals; B7-H1 Antigen; Cell Line, Tumor; Citric Acid; Combined Modality Therapy; Female; Ferrous Compounds; Heme Oxygenase-1; Hepatitis A Virus Cellular Receptor 2; Ki-67 Antigen; Lymphocyte Activation; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondria; Nuclear Respiratory Factor 1; Oxygen Consumption; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sirtuin 1 | 2021 |
Gossypitrin, A Naturally Occurring Flavonoid, Attenuates Iron-Induced Neuronal and Mitochondrial Damage.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Survival; Citric Acid; Ferrous Compounds; Flavonoids; Iron; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurons; Rats | 2021 |
5-Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila.
Topics: Aminolevulinic Acid; Animals; Citric Acid; Drosophila; Drosophila melanogaster; Ferrous Compounds; Muscles | 2022 |
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis.
Topics: Aminolevulinic Acid; Animals; Citric Acid; COVID-19 Drug Treatment; Ferrous Compounds; Heme; Heme Oxygenase-1; Humans; SARS-CoV-2; Sodium; Zika Virus; Zika Virus Infection | 2022 |
5-Aminolevulinic acid combined with sodium ferrous citrate mitigates effects of heat stress on bovine oocyte developmental competence.
Topics: Aminolevulinic Acid; Animals; Blastocyst; Cattle; Citric Acid; Cumulus Cells; Female; Ferrous Compounds; Heat-Shock Response; In Vitro Oocyte Maturation Techniques; Oocytes | 2022 |
Sodium ferrous citrate and 5-aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health.
Topics: Aminolevulinic Acid; Animals; Citric Acid; Diabetes Mellitus, Type 2; Diet, High-Fat; DNA, Mitochondrial; Ferrous Compounds; Insulin Resistance; Mice; Mice, Inbred C57BL; Mitochondria; Muscle, Skeletal | 2023 |